Amneal Pharmaceuticals, Inc. financial data

Symbol
AMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, 3 Rd Floor, Bridgewater, NJ
Fiscal year end
December 31
Former names
Atlas Holdings, Inc. (to 4/13/2018)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % -20.8%
Quick Ratio 59.7 % -18.2%
Return On Equity 369 % +21792%
Return On Assets -5.17 % -7379%
Operating Margin 7 % -26.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 310M shares
Entity Public Float 464M USD -1.44%
Weighted Average Number of Shares Outstanding, Basic 310M shares +101%
Weighted Average Number of Shares Outstanding, Diluted 310M shares +93.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.68B USD +12.3%
Research and Development Expense 183M USD +14.2%
Operating Income (Loss) 188M USD -17%
Nonoperating Income (Expense) -311M USD -63%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -123M USD -447%
Income Tax Expense (Benefit) 23.3M USD
Net Income (Loss) Attributable to Parent -180M USD -6934%
Earnings Per Share, Basic -0.85 USD/shares -1517%
Earnings Per Share, Diluted -0.85 USD/shares -1517%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74M USD -14.9%
Accounts Receivable, after Allowance for Credit Loss, Current 546M USD +1.38%
Inventory, Net 596M USD +3.45%
Assets, Current 1.51B USD +3.93%
Property, Plant and Equipment, Net 431M USD -4.61%
Operating Lease, Right-of-Use Asset 43.3M USD -22.9%
Intangible Assets, Net (Excluding Goodwill) 780M USD -20.6%
Goodwill 598M USD -0.05%
Other Assets, Noncurrent 36.3M USD -59.3%
Assets 3.46B USD -6.13%
Accounts Payable, Current 235M USD +32.5%
Employee-related Liabilities, Current 64.9M USD +22.9%
Liabilities, Current 1.1B USD +44%
Other Liabilities, Noncurrent 41.5M USD +26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -73.8M USD -2005%
Retained Earnings (Accumulated Deficit) -576M USD -47.1%
Stockholders' Equity Attributable to Parent -93.4M USD -128%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -93.6M USD -161%
Liabilities and Equity 3.46B USD -6.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.41M USD -103%
Net Cash Provided by (Used in) Financing Activities -23.2M USD -79.5%
Net Cash Provided by (Used in) Investing Activities -19.8M USD -68.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -47.5M USD -141%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 78.3M USD -18.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 64.5M USD +57.1%
Deferred Tax Assets, Valuation Allowance 565M USD +29.9%
Deferred Tax Assets, Gross 567M USD +30.3%
Operating Lease, Liability 48.9M USD -17.4%
Payments to Acquire Property, Plant, and Equipment 9.2M USD -5.06%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -263M USD -16785%
Lessee, Operating Lease, Liability, to be Paid 61.3M USD -19.3%
Property, Plant and Equipment, Gross 956M USD +4.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.5M USD -12.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 16M USD +0.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.4M USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.7M USD -25%
Deferred Tax Assets, Operating Loss Carryforwards 74.3M USD -9.71%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 3.74M USD +3.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.74M USD -25.5%
Additional Paid in Capital 553M USD -22.7%
Amortization of Intangible Assets 164M USD -1.91%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%